Project Grant HT94252311009
Award Date 9/1/23
Completion Date 8/31/26
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40526, USA
Similar Awards
- This $1,054,933 Department of Defense Project Grant awarded to Purdue University under the Military Medical Research and Development program (CFDA 12.420) will fund research to target NNMT (nicotinamide N-methyltransferase) in order to inhibit obesity-associated breast cancer development and progression. The 3-year award period runs from September 1, 2023 to August 31, 2026. As the prime awardee, Purdue University will conduct the biomedical research to investigate medical solutions for this...
- The Project Grant award of $1,602,137.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding research conducted by The University of Kentucky Research Foundation. The research aims to target the MNK/GRP78 pathway to disrupt proteostasis rewiring in castration-resistant prostate cancer. The project will run from April 15, 2025 to April 14, 2028, with the goal of developing innovative medical solutions to address critical health challenges...
- This Defense Health Agency Project Grant award of $1,204,899 to Duke University, with a period of performance from January 1, 2024 to December 31, 2027, supports targeted vaccination research to treat and prevent endocrine-resistant ER+ breast cancer. The project aims to develop new treatments by targeting common resistance genes and neoepitope mutations. This grant is funded through the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports...
- This Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), provides $616,000.00 in funding to the University of South Alabama to investigate a novel molecular link between obesity and colorectal cancer progression. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical understanding and developing innovative medical solutions. The 2-year award...
- This federal Project Grant award of $694,987.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports innovative research by the University of North Carolina at Chapel Hill to develop advanced immunotherapeutics for breast cancer treatment. The project aims to transform healthcare for military service members, veterans, and the broader public by conducting basic, applied, and translational research on innovative medical...
- This $838,911 Project Grant awarded by the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research by The Institute For Cancer Research to identify regulators of PALB2 function and PARP inhibitor resistance in triple-negative breast cancer. The 3-year award, beginning January 2024, will fund work to advance the understanding of genetic and molecular mechanisms underlying treatment resistance in this aggressive form of breast cancer. As a prime...
- The University of Louisville received a $1,015,291 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award will support research from March 2023 to February 2026 to investigate the epigenetic drivers of endocrine-resistant breast cancer. Through this funding, the University will conduct applied biomedical research focused on transforming healthcare and investigating medical solutions for...
- This $1,535,039 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development Program (CFDA 12.420) supports research conducted by Wake Forest University Health Sciences (WFUHS) to study how the breast tissue microbiota regulates immune checkpoint blockade therapy responsiveness in triple-negative breast cancer. The research aims to advance scientific understanding and develop new treatment approaches for this aggressive form of breast cancer that...
- This federal Project Grant award from the Defense Health Agency provides $1,555,000.00 to the University of North Carolina at Chapel Hill to support their research project titled "TARGETING OBESITY VIA DIET AND DRUGS FOR THE TREATMENT OF ENDOMETRIAL CANCER". The award is funded under the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports advanced biomedical research initiatives focused on transforming healthcare for military personnel and...
- The University of Kentucky Research Foundation has been awarded a $612,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) from the Defense Health Agency. The grant will fund the development of a new personalized medicine model for high-risk pediatric sarcomas, with a performance period from August 1, 2024 to July 31, 2026. As the prime awardee, the Research Foundation will leverage its expertise in biomedical research and collaborative partnerships to...